Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Serum Urate, Genetic Variation, and Prostate Cancer Risk: Atherosclerosis Risk in Communities (ARIC) Study.

Wang A, Barber JR, Tin A, De Marzo AM, Kottgen A, Joshu CE, Platz EA.

Cancer Epidemiol Biomarkers Prev. 2019 Jul;28(7):1259-1261. doi: 10.1158/1055-9965.EPI-19-0161.

PMID:
31263056
2.

Prospective Association of Serum and Dietary Magnesium with Colorectal Cancer Incidence.

Polter EJ, Onyeaghala G, Lutsey PL, Folsom AR, Joshu CE, Platz EA, Prizment AE.

Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1292-1299. doi: 10.1158/1055-9965.EPI-18-1300. Epub 2019 Jun 5.

PMID:
31167754
3.

Association between greater leg length and increased incidence of colorectal cancer: the atherosclerosis risk in communities (ARIC) study.

Onyeaghala G, Lutsey PL, Demerath EW, Folsom AR, Joshu CE, Platz EA, Prizment AE.

Cancer Causes Control. 2019 Aug;30(8):791-797. doi: 10.1007/s10552-019-01192-0. Epub 2019 Jun 4.

PMID:
31165420
4.

Cancer Survivorship and Subclinical Myocardial Damage: The Atherosclerosis Risk in Communities (ARIC) Study.

Florido R, Lee AK, McEvoy JW, Hoogeveen RC, Koton S, Vitolins MZ, Shenoy C, Russell SD, Blumenthal RS, Ndumele CE, Ballantyne CM, Joshu CE, Platz EA, Selvin E.

Am J Epidemiol. 2019 Mar 30. pii: kwz088. doi: 10.1093/aje/kwz088. [Epub ahead of print]

PMID:
30927355
5.

TP53 missense mutation is associated with increased tumor-infiltrating T cells in primary prostate cancer.

Kaur HB, Lu J, Guedes LB, Maldonado L, Reitz L, Barber JR, De Marzo AM, Tomlins SA, Sfanos KS, Eisenberger M, Schaeffer EM, Joshu CE, Lotan TL.

Hum Pathol. 2019 May;87:95-102. doi: 10.1016/j.humpath.2019.02.006. Epub 2019 Mar 6.

PMID:
30851334
6.

Dietary choline and betaine intakes and risk of total and lethal prostate cancer in the Atherosclerosis Risk in Communities (ARIC) Study.

Han P, Bidulescu A, Barber JR, Zeisel SH, Joshu CE, Prizment AE, Vitolins MZ, Platz EA.

Cancer Causes Control. 2019 Apr;30(4):343-354. doi: 10.1007/s10552-019-01148-4. Epub 2019 Mar 1.

PMID:
30825046
7.

IBD as a risk factor for prostate cancer: what is the link?

Sfanos KS, Joshu CE.

Nat Rev Urol. 2019 May;16(5):271-272. doi: 10.1038/s41585-019-0157-7. No abstract available.

PMID:
30742047
8.

Hyperglycemia, Classified with Multiple Biomarkers Simultaneously in Men without Diabetes, and Risk of Fatal Prostate Cancer.

Marrone MT, Selvin E, Barber JR, Platz EA, Joshu CE.

Cancer Prev Res (Phila). 2019 Feb;12(2):103-112. doi: 10.1158/1940-6207.CAPR-18-0216. Epub 2018 Dec 11.

PMID:
30538098
9.

Adding the Team into T1 Translational Research: A Case Study of Multidisciplinary Team Science in the Evaluation of Biomarkers of Prostate Cancer Risk and Prognosis.

Marrone MT, Joshu CE, Peskoe SB, De Marzo AM, Heaphy CM, Lupold SE, Meeker AK, Platz EA.

Clin Chem. 2019 Jan;65(1):189-198. doi: 10.1373/clinchem.2018.293365. Epub 2018 Dec 5.

PMID:
30518666
10.

Discovery of common and rare genetic risk variants for colorectal cancer.

Huyghe JR, Bien SA, Harrison TA, Kang HM, Chen S, Schmit SL, Conti DV, Qu C, Jeon J, Edlund CK, Greenside P, Wainberg M, Schumacher FR, Smith JD, Levine DM, Nelson SC, Sinnott-Armstrong NA, Albanes D, Alonso MH, Anderson K, Arnau-Collell C, Arndt V, Bamia C, Banbury BL, Baron JA, Berndt SI, Bézieau S, Bishop DT, Boehm J, Boeing H, Brenner H, Brezina S, Buch S, Buchanan DD, Burnett-Hartman A, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Castellví-Bel S, Chan AT, Chang-Claude J, Chanock SJ, Chirlaque MD, Cho SH, Connolly CM, Cross AJ, Cuk K, Curtis KR, de la Chapelle A, Doheny KF, Duggan D, Easton DF, Elias SG, Elliott F, English DR, Feskens EJM, Figueiredo JC, Fischer R, FitzGerald LM, Forman D, Gala M, Gallinger S, Gauderman WJ, Giles GG, Gillanders E, Gong J, Goodman PJ, Grady WM, Grove JS, Gsur A, Gunter MJ, Haile RW, Hampe J, Hampel H, Harlid S, Hayes RB, Hofer P, Hoffmeister M, Hopper JL, Hsu WL, Huang WY, Hudson TJ, Hunter DJ, Ibañez-Sanz G, Idos GE, Ingersoll R, Jackson RD, Jacobs EJ, Jenkins MA, Joshi AD, Joshu CE, Keku TO, Key TJ, Kim HR, Kobayashi E, Kolonel LN, Kooperberg C, Kühn T, Küry S, Kweon SS, Larsson SC, Laurie CA, Le Marchand L, Leal SM, Lee SC, Lejbkowicz F, Lemire M, Li CI, Li L, Lieb W, Lin Y, Lindblom A, Lindor NM, Ling H, Louie TL, Männistö S, Markowitz SD, Martín V, Masala G, McNeil CE, Melas M, Milne RL, Moreno L, Murphy N, Myte R, Naccarati A, Newcomb PA, Offit K, Ogino S, Onland-Moret NC, Pardini B, Parfrey PS, Pearlman R, Perduca V, Pharoah PDP, Pinchev M, Platz EA, Prentice RL, Pugh E, Raskin L, Rennert G, Rennert HS, Riboli E, Rodríguez-Barranco M, Romm J, Sakoda LC, Schafmayer C, Schoen RE, Seminara D, Shah M, Shelford T, Shin MH, Shulman K, Sieri S, Slattery ML, Southey MC, Stadler ZK, Stegmaier C, Su YR, Tangen CM, Thibodeau SN, Thomas DC, Thomas SS, Toland AE, Trichopoulou A, Ulrich CM, Van Den Berg DJ, van Duijnhoven FJB, Van Guelpen B, van Kranen H, Vijai J, Visvanathan K, Vodicka P, Vodickova L, Vymetalkova V, Weigl K, Weinstein SJ, White E, Win AK, Wolf CR, Wolk A, Woods MO, Wu AH, Zaidi SH, Zanke BW, Zhang Q, Zheng W, Scacheri PC, Potter JD, Bassik MC, Kundaje A, Casey G, Moreno V, Abecasis GR, Nickerson DA, Gruber SB, Hsu L, Peters U.

Nat Genet. 2019 Jan;51(1):76-87. doi: 10.1038/s41588-018-0286-6. Epub 2018 Dec 3.

11.

Aspirin and Non-Aspirin NSAID Use and Prostate Cancer Incidence, Mortality, and Case Fatality in the Atherosclerosis Risk in Communities Study.

Hurwitz LM, Joshu CE, Barber JR, Prizment AE, Vitolins MZ, Jones MR, Folsom AR, Han M, Platz EA.

Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):563-569. doi: 10.1158/1055-9965.EPI-18-0965. Epub 2018 Nov 28.

PMID:
30487131
12.

A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk.

Travis RC, Perez-Cornago A, Appleby PN, Albanes D, Joshu CE, Lutsey PL, Mondul AM, Platz EA, Weinstein SJ, Layne TM, Helzlsouer KJ, Visvanathan K, Palli D, Peeters PH, Bueno-de-Mesquita B, Trichopoulou A, Gunter MJ, Tsilidis KK, Sánchez MJ, Olsen A, Brenner H, Schöttker B, Perna L, Holleczek B, Knekt P, Rissanen H, Yeap BB, Flicker L, Almeida OP, Wong YYE, Chan JM, Giovannucci EL, Stampfer MJ, Ursin G, Gislefoss RE, Bjørge T, Meyer HE, Blomhoff R, Tsugane S, Sawada N, English DR, Eyles DW, Heath AK, Williamson EJ, Manjer J, Malm J, Almquist M, Marchand LL, Haiman CA, Wilkens LR, Schenk JM, Tangen CM, Black A, Cook MB, Huang WY, Ziegler RG, Martin RM, Hamdy FC, Donovan JL, Neal DE, Touvier M, Hercberg S, Galan P, Deschasaux M, Key TJ, Allen NE.

Cancer Res. 2019 Jan 1;79(1):274-285. doi: 10.1158/0008-5472.CAN-18-2318. Epub 2018 Nov 13.

13.

When Is Enough, Enough? When Are More Observational Epidemiologic Studies Needed to Resolve a Research Question: Illustrations Using Biomarker-Cancer Associations.

Marrone MT, Tsilidis KK, Ehrhardt S, Joshu CE, Rebbeck TR, Sellers TA, Platz EA.

Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):239-247. doi: 10.1158/1055-9965.EPI-18-0660. Epub 2018 Oct 30.

PMID:
30377205
14.

Longer-term Lipid-lowering Drug Use and Risk of Incident and Fatal Prostate Cancer in Black and White Men in the ARIC Study.

Mondul AM, Joshu CE, Barber JR, Prizment AE, Bhavsar NA, Selvin E, Folsom AR, Platz EA.

Cancer Prev Res (Phila). 2018 Dec;11(12):779-788. doi: 10.1158/1940-6207.CAPR-17-0396. Epub 2018 Oct 16.

PMID:
30327368
15.

Racial differences in maternal and umbilical cord blood leukocyte telomere length and their correlations.

Weber KA, Heaphy CM, Joshu CE, Lu J, Rohrmann S, Bienstock JL, Agurs-Collins T, Meeker AK, Platz EA.

Cancer Causes Control. 2018 Aug;29(8):759-767. doi: 10.1007/s10552-018-1054-8. Epub 2018 Jul 6.

16.

Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts.

McCullough ML, Zoltick ES, Weinstein SJ, Fedirko V, Wang M, Cook NR, Eliassen AH, Zeleniuch-Jacquotte A, Agnoli C, Albanes D, Barnett MJ, Buring JE, Campbell PT, Clendenen TV, Freedman ND, Gapstur SM, Giovannucci EL, Goodman GG, Haiman CA, Ho GYF, Horst RL, Hou T, Huang WY, Jenab M, Jones ME, Joshu CE, Krogh V, Lee IM, Lee JE, Männistö S, Le Marchand L, Mondul AM, Neuhouser ML, Platz EA, Purdue MP, Riboli E, Robsahm TE, Rohan TE, Sasazuki S, Schoemaker MJ, Sieri S, Stampfer MJ, Swerdlow AJ, Thomson CA, Tretli S, Tsugane S, Ursin G, Visvanathan K, White KK, Wu K, Yaun SS, Zhang X, Willett WC, Gail MH, Ziegler RG, Smith-Warner SA.

J Natl Cancer Inst. 2019 Feb 1;111(2):158-169. doi: 10.1093/jnci/djy087.

17.

Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer.

Kaur HB, Guedes LB, Lu J, Maldonado L, Reitz L, Barber JR, De Marzo AM, Tosoian JJ, Tomlins SA, Schaeffer EM, Joshu CE, Sfanos KS, Lotan TL.

Mod Pathol. 2018 Oct;31(10):1539-1552. doi: 10.1038/s41379-018-0083-x. Epub 2018 May 30.

18.

Polymorphisms in genes related to inflammation and obesity and colorectal adenoma risk.

Huang BZ, Tsilidis KK, Smith MW, Hoffman-Bolton J, Visvanathan K, Platz EA, Joshu CE.

Mol Carcinog. 2018 Oct;57(10):1278-1288. doi: 10.1002/mc.22842. Epub 2018 Jun 5.

19.

Cost implications of PSA screening differ by age.

Rao K, Liang S, Cardamone M, Joshu CE, Marmen K, Bhavsar N, Nelson WG, Ballentine Carter H, Albert MC, Platz EA, Pollack CE.

BMC Urol. 2018 May 9;18(1):38. doi: 10.1186/s12894-018-0344-5.

20.

A unique telomere DNA expansion phenotype in human retinal rod photoreceptors associated with aging and disease.

Bell WR, Meeker AK, Rizzo A, Rajpara S, Rosenthal IM, Flores Bellver M, Aparicio Domingo S, Zhong X, Barber JR, Joshu CE, Canto-Soler MV, Eberhart CG, Heaphy CM.

Brain Pathol. 2019 Jan;29(1):45-52. doi: 10.1111/bpa.12618. Epub 2018 May 23.

PMID:
29668072
21.

Periodontal Disease Assessed Using Clinical Dental Measurements and Cancer Risk in the ARIC Study.

Michaud DS, Lu J, Peacock-Villada AY, Barber JR, Joshu CE, Prizment AE, Beck JD, Offenbacher S, Platz EA.

J Natl Cancer Inst. 2018 Aug 1;110(8):843-854. doi: 10.1093/jnci/djx278.

22.

Enhancing the Infrastructure of the Atherosclerosis Risk in Communities (ARIC) Study for Cancer Epidemiology Research: ARIC Cancer.

Joshu CE, Barber JR, Coresh J, Couper DJ, Mosley TH, Vitolins MZ, Butler KR, Nelson HH, Prizment AE, Selvin E, Tooze JA, Visvanathan K, Folsom AR, Platz EA.

Cancer Epidemiol Biomarkers Prev. 2018 Mar;27(3):295-305. doi: 10.1158/1055-9965.EPI-17-0696. Epub 2017 Dec 20.

23.

Current or recent smoking is associated with more variable telomere length in prostate stromal cells and prostate cancer cells.

Joshu CE, Peskoe SB, Heaphy CM, Kenfield SA, Mucci LA, Giovannucci EL, Stampfer MJ, Yoon G, Lee TK, Hicks JL, De Marzo AM, Meeker AK, Platz EA.

Prostate. 2018 Feb;78(3):233-238. doi: 10.1002/pros.23462. Epub 2017 Nov 22.

24.

Racial/Ethnic Differences in the Associations of Overall and Central Body Fatness with Circulating Hormones and Metabolic Factors in US Men.

Lopez DS, Rohrmann S, Peskoe SB, Joshu CE, Tsilidis KK, Selvin E, Dobs AS, Kanarek N, Canfield S, Nelson WG, Platz EA.

Int J Endocrinol Metab. 2017 Apr 22;15(2):e44926. doi: 10.5812/ijem.44926. eCollection 2017 Apr.

25.

A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts.

Platz EA, Kulac I, Barber JR, Drake CG, Joshu CE, Nelson WG, Lucia MS, Klein EA, Lippman SM, Parnes HL, Thompson IM, Goodman PJ, Tangen CM, De Marzo AM.

Cancer Epidemiol Biomarkers Prev. 2017 Oct;26(10):1549-1557. doi: 10.1158/1055-9965.EPI-17-0503. Epub 2017 Jul 28.

26.

Early Life Exposures and Adult Cancer Risk.

Clarke MA, Joshu CE.

Epidemiol Rev. 2017 Jan 1;39(1):11-27. doi: 10.1093/epirev/mxx004. Review.

27.

Physical Activity and Lifetime Risk of Cardiovascular Disease and Cancer.

Kubota Y, Evenson KR, Maclehose RF, Roetker NS, Joshu CE, Folsom AR.

Med Sci Sports Exerc. 2017 Aug;49(8):1599-1605. doi: 10.1249/MSS.0000000000001274.

28.

Racial/Ethnic Differences in Duration of Smoking Among Former Smokers in the National Health and Nutrition Examination Surveys.

Jones MR, Joshu CE, Navas-Acien A, Platz EA.

Nicotine Tob Res. 2018 Feb 7;20(3):303-311. doi: 10.1093/ntr/ntw326.

29.

High-resolution telomere fluorescence in situ hybridization reveals intriguing anomalies in germ cell tumors.

Shekhani MT, Barber JR, Bezerra SM, Heaphy CM, Gonzalez Roibon ND, Taheri D, Reis LO, Guner G, Joshu CE, Netto GJ, Meeker AK.

Hum Pathol. 2016 Aug;54:106-12. doi: 10.1016/j.humpath.2016.03.015. Epub 2016 Apr 13.

PMID:
27085557
30.

Cigarette Smoking and Prostate Cancer Mortality in Four US States, 1999-2010.

Jones MR, Joshu CE, Kanarek N, Navas-Acien A, Richardson KA, Platz EA.

Prev Chronic Dis. 2016 Apr 14;13:E51. doi: 10.5888/pcd13.150454.

31.

Cross-sectional association between physical activity and serum testosterone levels in US men: results from NHANES 1999-2004.

Steeves JA, Fitzhugh EC, Bradwin G, McGlynn KA, Platz EA, Joshu CE.

Andrology. 2016 May;4(3):465-72. doi: 10.1111/andr.12169. Epub 2016 Mar 16.

32.

Predictors of Human Papillomavirus Vaccination in a Large Clinical Population of Males Aged 11 to 26 years in Maryland, 2012-2013.

Clarke MA, Coutinho F, Phelan-Emrick DF, Wilbur M, Chou B, Joshu CE.

Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):351-8. doi: 10.1158/1055-9965.EPI-15-0983. Epub 2015 Dec 23.

33.

Postpartum Teens' Perception of the Food Environments at Home and School.

Tabak RG, Joshu CE, Clarke MA, Schwarz CD, Haire-Joshu DL.

Health Educ Behav. 2016 Feb;43(1):76-85. doi: 10.1177/1090198115596734. Epub 2015 Aug 13.

34.

A group randomized controlled trial integrating obesity prevention and control for postpartum adolescents in a home visiting program.

Haire-Joshu DL, Schwarz CD, Peskoe SB, Budd EL, Brownson RC, Joshu CE.

Int J Behav Nutr Phys Act. 2015 Jun 26;12:88. doi: 10.1186/s12966-015-0247-8.

35.

Prediagnostic Obesity and Physical Inactivity Are Associated with Shorter Telomere Length in Prostate Stromal Cells.

Joshu CE, Peskoe SB, Heaphy CM, Kenfield SA, Van Blarigan EL, Mucci LA, Giovannucci EL, Stampfer MJ, Yoon G, Lee TK, Hicks JL, De Marzo AM, Meeker AK, Platz EA.

Cancer Prev Res (Phila). 2015 Aug;8(8):737-42. doi: 10.1158/1940-6207.CAPR-15-0097. Epub 2015 May 19.

36.

Influence of home and school environments on specific dietary behaviors among postpartum, high-risk teens, 27 States, 2007-2009.

Clarke MA, Haire-Joshu DL, Schwarz CD, Tabak RG, Joshu CE.

Prev Chronic Dis. 2015 May 7;12:E68. doi: 10.5888/pcd12.140437.

37.

Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer.

Peskoe SB, Joshu CE, Rohrmann S, McGlynn KA, Nyante SJ, Bradwin G, Dobs AS, Kanarek N, Nelson WG, Platz EA.

Prostate. 2015 Aug 1;75(11):1167-76. doi: 10.1002/pros.22998. Epub 2015 Apr 28.

38.

Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial.

Heaphy CM, Gaonkar G, Peskoe SB, Joshu CE, De Marzo AM, Lucia MS, Goodman PJ, Lippman SM, Thompson IM Jr, Platz EA, Meeker AK.

Prostate. 2015 Aug 1;75(11):1160-6. doi: 10.1002/pros.22997. Epub 2015 Apr 20.

39.

Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer.

Julin B, Shui I, Heaphy CM, Joshu CE, Meeker AK, Giovannucci E, De Vivo I, Platz EA.

Br J Cancer. 2015 Feb 17;112(4):769-76. doi: 10.1038/bjc.2014.640. Epub 2015 Jan 6.

40.

Do environmental factors modify the genetic risk of prostate cancer?

Loeb S, Peskoe SB, Joshu CE, Huang WY, Hayes RB, Carter HB, Isaacs WB, Platz EA.

Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):213-20. doi: 10.1158/1055-9965.EPI-14-0786-T. Epub 2014 Oct 23.

41.

Body mass index at early adulthood, subsequent weight change and cancer incidence and mortality.

Han X, Stevens J, Truesdale KP, Bradshaw PT, Kucharska-Newton A, Prizment AE, Platz EA, Joshu CE.

Int J Cancer. 2014 Dec 15;135(12):2900-9. doi: 10.1002/ijc.28930. Epub 2014 May 8.

42.

The association between circulating high-sensitivity C-reactive protein concentration and pathologic measures of colonic inflammation.

Joshu CE, Tsilidis KK, Peskoe SB, Giardiello FM, Dluzniewski PJ, Nelson WG, Iacobuzio-Donahue CA, Platz EA.

Cancer Causes Control. 2014 Apr;25(4):409-18. doi: 10.1007/s10552-014-0343-0. Epub 2014 Jan 17.

43.

Association between endogenous sex steroid hormones and insulin-like growth factor proteins in US men.

Papatheodorou SI, Rohrmann S, Lopez DS, Bradwin G, Joshu CE, Kanarek N, Nelson WG, Rifai N, Platz EA, Tsilidis KK.

Cancer Causes Control. 2014 Mar;25(3):353-63. doi: 10.1007/s10552-013-0336-4. Epub 2014 Jan 7.

44.

Telomere length as a risk factor for hereditary prostate cancer.

Hurwitz LM, Heaphy CM, Joshu CE, Isaacs WB, Konishi Y, De Marzo AM, Isaacs SD, Wiley KE, Platz EA, Meeker AK.

Prostate. 2014 Apr;74(4):359-64. doi: 10.1002/pros.22755. Epub 2013 Nov 28.

45.

Association between endogenous sex steroid hormones and inflammatory biomarkers in US men.

Tsilidis KK, Rohrmann S, McGlynn KA, Nyante SJ, Lopez DS, Bradwin G, Feinleib M, Joshu CE, Kanarek N, Nelson WG, Selvin E, Platz EA.

Andrology. 2013 Nov;1(6):919-28. doi: 10.1111/j.2047-2927.2013.00129.x. Epub 2013 Sep 30.

46.

Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study.

Prizment AE, Folsom AR, Dreyfus J, Anderson KE, Visvanathan K, Joshu CE, Platz EA, Pankow JS.

Cancer Causes Control. 2013 Dec;24(12):2077-87. doi: 10.1007/s10552-013-0285-y. Epub 2013 Sep 14.

47.

Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death.

Heaphy CM, Yoon GS, Peskoe SB, Joshu CE, Lee TK, Giovannucci E, Mucci LA, Kenfield SA, Stampfer MJ, Hicks JL, De Marzo AM, Platz EA, Meeker AK.

Cancer Discov. 2013 Oct;3(10):1130-41. doi: 10.1158/2159-8290.CD-13-0135. Epub 2013 Jun 18.

48.

Racial/ethnic differences in serum sex steroid hormone concentrations in US adolescent males.

Lopez DS, Peskoe SB, Joshu CE, Dobs A, Feinleib M, Kanarek N, Nelson WG, Selvin E, Rohrmann S, Platz EA.

Cancer Causes Control. 2013 Apr;24(4):817-26. doi: 10.1007/s10552-013-0154-8. Epub 2013 Jan 25.

49.

Incidence and progression of lower urinary tract symptoms in a large prospective cohort of United States men.

Platz EA, Joshu CE, Mondul AM, Peskoe SB, Willett WC, Giovannucci E.

J Urol. 2012 Aug;188(2):496-501. doi: 10.1016/j.juro.2012.03.125. Epub 2012 Jun 15.

50.

Urban sprawl, physical activity, and body mass index: Nurses' Health Study and Nurses' Health Study II.

James P, Troped PJ, Hart JE, Joshu CE, Colditz GA, Brownson RC, Ewing R, Laden F.

Am J Public Health. 2013 Feb;103(2):369-75. doi: 10.2105/AJPH.2011.300449. Epub 2012 Jun 14.

Supplemental Content

Loading ...
Support Center